Similar articles

• Additional Insights Into the Use of Preterm Formula Among Neonates.

  Alshaikh BN, Fenton TR. Alshaikh BN, et al. JAMA Pediatr. 2021 Dec 1;175(12):1285-1286. doi: 10.1001/jamapediatrics.2021.3134. JAMA Pediatr. 2021. PMID: 34459866 No abstract available.
• Additional Insights Into the Use of Preterm Formula Among Neonates-Reply.

  Sharma A, Chinnappan A, Sankar MJ. Sharma A, et al. JAMA Pediatr. 2021 Dec 1;175(12):1287. doi: 10.1001/jamapediatrics.2021.3140. JAMA Pediatr. 2021. PMID: 34459873 No abstract available.
• Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

  Giapros VI, Papaloukas AL, Challa AS, Nikolopoulos PD, Tsampoulas CG, Andronikou SK. Giapros VI, et al. Eur J Pediatr. 2003 Jul;162(7-8):481-487. doi: 10.1007/s00431-003-1209-8. Epub 2003 May 16. Eur J Pediatr. 2003. PMID: 12750999
• Dilute versus full-strength formula in exclusively formula-fed preterm or low birth weight infants.

  Basuki F, Hadiati DR, Turner T, McDonald S, Hakimi M. Basuki F, et al. Cochrane Database Syst Rev. 2019 Jun 27;6(6):CD007263. doi: 10.1002/14651858.CD007263.pub3. Cochrane Database Syst Rev. 2019. PMID: 31246272 Free PMC article.
• Extensive and partial protein hydrolysate preterm formulas.

  Szajewska H. Szajewska H. J Pediatr Gastroenterol Nutr. 2007 Dec;45 Suppl 3:S183-7. doi: 10.1097/01.mpg.0000302969.60373.39. J Pediatr Gastroenterol Nutr. 2007. PMID: 18185089 Review.